chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Clinical Summary: Patient is a 71 y.o. female with history of chronic fatigue and pain, atrial fibrillation (on Eliquis), and migraines, admitted to the hospital on 8/15/2022 for worsening weakness and fatigue. Her husband was diagnosed with COVID-19 ~10 days prior to this admission. She presented to ED previously on 8/13/22 and tested positive for COVID-19 herself. States for the week leading up to admission she has been feeling increased fatigue and generalized weakness. This has significantly worsened in 48 hours prior to admission to the point where she had decreased oral intake of both food and fluids. Husband felt overwhelmed and incapable of meeting her level of need at home. In the ED CBC and Chem7 were unremarkable. Lactic acid 1.4 and Creatinine 0.94. Chest and head imaging were non-acute. She was started on 75 mL / hr. of LR and PT/OT was consulted. She did not require supplemental oxygen at the time of admission or throughout her stay. Patient has a baseline level of low mood, anhedonia, and decreased functionality at home. She answers many questions with "I don't know" but is Aox4 and can go on to answer many questions after gentle probing. Her potassium did drop to 3.0 and was replete on 8/16. PT/OT saw the patient and recommended 2 - 3 days of rehab weekly for 7 - 10 days. The patient was approved for home health care through local service provider. She was discharged in stable condition. Discharge Diagnosis and Associated Hospital Course: Weakness Fatigue COVID-19 Infection Acute on chronic decompensation, presumably 2/2 COVID-19. Gave supportive care with IV fluids and encouraging PO intake. PT / OT saw patient and gave recommendations for outpatient rehabilitation. She was accepted and set up with local provider for her rehab. Atrial Fibrillation Cardiovascular Risk Longstanding diagnosis. Stable on Eliquis 5 mg BID and Simvastatin 20 mg daily at home. These medications were continued for this admission. Low Platelets. Patient was 127K on admission and decreased as low as 105K before rebounding. Presumed 2/2 dilution from IV fluids. Asymptomatic. Hypokalemia Patient was 3.8 on admission and dropped to 3.0. Replete with 80 mEq and on day of discharge was 3.7. Chronic Pain Peripheral Neuropathy Migraines Taking gabapentin 300 mg TID and Topamax 200 mg BID at home. Continued home medications. Insomnia Taking PRN Trazodone 150 mg nightly at home. Continued home medications. Peptic Ulcer Disease / GERD Taking Pepcid 40 mg and Protonix 40 mg daily at home. Continued home medications. Dry Eyes Taking Xiidra 5% droplets PRN at home. Gave liquid tears PRN in hospital.
Pt developed half-dollar size area of redness with raised area at center of red area. No other signs and symptoms of difficulty. Pt sent home with Benadryl per mouth (parents to dispense for 2 days).
covid arm from the shoulder to the elbow; it was red, very itchy and lasted a month; it was red, very itchy and lasted a month; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (covid arm from the shoulder to the elbow), ERYTHEMA (it was red, very itchy and lasted a month) and PRURITUS (it was red, very itchy and lasted a month) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A, 023M20A and 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified. Concomitant products included VERAPAMIL for Heart disease, unspecified.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (covid arm from the shoulder to the elbow), ERYTHEMA (it was red, very itchy and lasted a month) and PRURITUS (it was red, very itchy and lasted a month). At the time of the report, IMMUNISATION REACTION (covid arm from the shoulder to the elbow) outcome was unknown and ERYTHEMA (it was red, very itchy and lasted a month) and PRURITUS (it was red, very itchy and lasted a month) had resolved.            Patient did not have patient had positive COVID test or diagnosis. Treatment details was not reported by the reporter.
MMR on 11/26. 6pm 11/26 B axillary rash development. Seen 12/5/02, rash has involved large area B axiallary region. Erythema patches, some with ?, itchy, no other  signs or symptoms.
Initial report was received on 12 September 2012 from a consumer from an unverified internet source, who is also the patient. This is a non valid case as contact details for a Healthcare Professional were not provided. A female patient (age and date of birth not reported), had received an INFLUENZA VACCINE (manufacturer unknown; lot number, route, site and date of administration not reported) and an unspecified amount of time later, she "developed a lung abscess when she received it". The patient was hospitalized for three weeks and received IV antibiotic for six months (dates not reported). Outcome was not reported. No additional information was provided at the time of the report. Documents held by sender: None.
Patient passed out and regained consciousness after a few seconds. She slowly came to afterwards and ended up insisting on driving herself home. Followed up after she got home and she was okay.
Patient states 2 to 3 days after vaccine was given on 6/7/2007, he experienced a tingly sensation under his skin and on top of skin which is now subsiding
severe joint pain after second shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (severe joint pain after second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (severe joint pain after second shot). At the time of the report, ARTHRALGIA (severe joint pain after second shot) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.  Action taken in response to mRNA-1273 was considered to be not applicable.
Case number PHEH2015US017655, is an initial spontaneous report from a nurse received on 09 Sep 2015. This report refers to a 55-year-old male patient. Medical history was not reported. Concomitant medication was not reported. Vaccination history included administration of FLUVIRIN (batch number: not reported) three times and the patient tolerated the vaccinations. Concomitant medication was not reported. The patient was vaccinated with 0.5 ml of FLUVIRN (batch number: 1557103) intramuscular at left deltoid on 10 Sep 2015 (at 09:00). It was reported that patient received an out of temperature range FLUVIRIN pre filled syringe which was stored at a temperature range of 33.2F. The case was reported as non-serious. No adverse reaction was experienced by the patient following this medication error. Follow up report from the nurse received on 27 Oct 2015. Updated patient's demographics, vaccination history, vaccination time, vaccination sire and other clinically relevant information in the narrative.
Patient is a 18 y C/F with HO uncontrolled insulin dependent diabetes mellitus - diagnosed at age 15, likely type I with history of recurrent DKA with last admission in Sept 2021. Admitted to the hospital for 2 days with the chief complaint of elevated blood sugars. She is on Insulin Lantus and Lispro. States that she takes her insulin regularly. Her last A1c in the system is from March 2021 elevated at 15. She states that she used to follow up with pediatric endocrinologist and has now aged out and is trying to get with an adult endocrinology. Her insulin regimen is currently being managed by her PCP. She states that she has been having severe head ache, nausea, and some trouble breathing because of which she came to the ER. Based on her prior episodes she felt that she might be in DKA which made her come to the ER.    At the time of admission she was noted to have blood sugar of 379, anion gap elevated, venous blood gas showed PH 6.98, Beta hydroxy butyrate elevated at 8.29. UA negative for infection. CXR negative for infiltrates. She tested positive for COVID 19 infection. Admitted to moderate care with DKA protocol
Injection approx 530pm Friday Jan 15. "By midnight I had a fever over 101F.. body aches with chills and involuntary shivering.  My skin and joints felt inflamed and very hot. The injection arm was untouchable and hurt badly for 48 hrs.  The pain was close to excruciating.  It hurt to move it hurt to stay still.  I moaned and cried in pain.   I treated it with motrin and Tylenol alternately. I felt a little relief sat at 2pm then it kicked back in around 6pm sat night.  Through sun and Mon the pain faded a little at a time and I still get shooting pain into my joints.  My insides were so raw I acquired a scratch down the back of my throat and probably esophagus that is still blistered and I can taste the ulcerations.  I have never had a reaction to flu or other vaccines.  I expected achey etc but this was a little extreme!  I had blood on my qtips this morning from my ears. " Advised to contact PCP ASAP.
Admission Date: 8/31/2022 Discharge Date: 9/5/2022  PRESENTING PROBLEM: Dehydration [E86.0] General weakness [R53.1] Muscular deconditioning [R29.898] AKI (acute kidney injury) (HCC) [N17.9] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Patient is a very pleasant 93-year-old male presenting with generalized weakness uncontrolled pain related his sacral fraction and hypotension.  Patient was admitted patient's diuretics were held patient was hydrated patient empirically treated Decadron for his COVID-19.  Patient's renal insufficiency improved with hydration patient's blood pressure improved with treatment patient was empirically covered with doxycycline and Rocephin during hospitalization.  Patient's pain improved was able low work with PT and OT with recommendations for subacute rehab.  The patient stable normal renal function good saturation hypotension resolved.  Patient is back on his home medications with exception of Lasix which will be dosed daily for a greater than or equal to 2 lb weight gain along with his potassium chloride patient need labs within a week to re-evaluate his blood count and his kidney function electrolytes.  Patient in stable condition for discharge to subacute rehab
EXPER. FLU-LIKE SYMPTOMS, FEVER 1.5 HRS AFTER VAX(IM,DELT) NO RASH. NO MED GIVEN TO TREAT SYMPTOMS. RECOVERY 30-MAR-90. PHYS FEELS IT WAS FLU.  SUBSEQUENT VAX IS PLANNED.
My adverse reaction began at 1:00 am on 5/14/2021. I had experienced body aches earlier in the evening, but at 1:00 I awoke with a fever of 101.2, severe body aches, extreme thirst despite drinking a lot of water earlier in the evening. This fever persisted until 6:00 am this morning, 5/15/2021. The body aches are persisting, however have diminished. There was not a time in more than 36 hours that my temp was under 101.2, the highest reading being 101.8.  This fever was accompanied by nausea, headache, severe body aches and nearly constant shivering.   I have been a Registered Nurse for 37 years, and I am a very healthy individual. I have none of the co-morbidities that are related to Covid-19. I am utterly appalled that people are not being advised, or warned about the possible side effects of this vaccine. If any other medication on the market carried the possibility of this type of side effect, and patients were not being warned, there would be lawsuits happening everywhere.   I would like to know the rate at which reactions like the one I've experienced are occuring.
This case was obtained from a consumer and a health care professional via a non-scientific (Lay press) publication on 31 October 2011. A 77-year-old female patient received an injection (route and site not reported) of TETANUS TOXOID, manufacturer and lot number unknown, twelve years ago (date not provided). The patient was in good health. The patient had an Arthus reaction to tetanus vaccine twelve years ago. "There was considerable swelling at the injection site. I also had chills and fever, aches all over and just plain felt miserable". It was recommended to the patient by a newspaper doctor to not get another shot unless an allergist felt it is safe. She was urged to meticulously clean all puncture wounds that occurred in situations where soil of dirt could enter the wound. The outcome was recovered. Documents held by sender: None.
R neck got swollen 11 days after vaccine. Went to Urgent care and was transferred to ER. Diagnosed with lymphadenopathy
0820 Syncopal episode (approx 2 minutes in length) immediately after being vaccinated with flu vaccine. Two person assist from chair to treatment bed. BP 118/62 HR 80 resp 18. Aware of surroundings. Verbalized needed to get to work. Ammonia capsule used.  0827 after sitting up for 3 minutes and denying dizziness, assisted to waiting area. 0830 summoned to waiting area. Pt seen slumped on chair then experiencing full body tremors for 30 seconds. Sat up and covered face with hands. Pale and diaphoretic. Call placed to  ED and transferred to ED via WC. Offered to call someone for her. She had just sent a text message to her mother.
Arm Pain (first vaccine on April 3rd on right arm, pain began on rt side arm about 2-3 days after words, fingers get numb when holding phone, gets especially bad when laying down and going to bed, shooting burning and numbing pain, rt hand and arm are weak)
An itchy rash formed on arms the day after and spread to back. He tried BENADRYL but it did not relieve symptoms. He saw doctor.
On March 10, the patient had what has become an almost daily "episode" that I would most closely describe as a panic attack with hallucinations.  He becomes very disoriented, stating that images appear and words sound very fast to him.  When he tries to describe what is happening to him he has a hard time explaining it.  After the episode is over is able to articulate what he experienced.  This is completely out of character for him.  He is very social, is a good student and athlete.
-During the evening of 1/13 I had some itching at the vaccine injection site.   The following morning I had a large warm red mark roughly 4" wide and 6" in length.    -After each day the original location would go away and another area lower and smaller would appear.    It took another 4-6 days to completely disappear and no other spots to appear.
Shortness of breath; Severe numbness and tingling in all limbs, both arms and legs, hands and feet.; Severe numbness and tingling in all limbs, both arms and legs, hands and feet.; Very sore armpit on same side as injection site; This is a spontaneous report from a non-contactable consumer or other non hcp. A 50-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 03May2021 12:00 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization. Medical history included Raynaud's phenomenon from an unknown date and unknown if ongoing, menopause from an unknown date and unknown if ongoing and Historical Vaccine BNT162B2 (Dose number: 1) for COVID-19 immunization in on an unspecified date in Apr2021. The patient's concomitant medications were not reported. The patient experienced shortness of breath, severe numbness and tingling in all limbs, both arms and legs, hands and feet, very sore armpit on same side as injection site on an unspecified date. There were no other vaccines in four weeks. There was no treatment received. Patient did not have Covid prior vaccination. Patient was not Covid tested post vaccination. The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. And there were not any other medications the patient received within 2 weeks of vaccination. The outcome of events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
both doses, throat tightness; This is a spontaneous report from a contactable physician. A 63-years-old female patient received bnt162b2 (BNT162B2) via an unspecified route of administration on an unspecified date (Batch/Lot Number: FN6205) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included asthma, environmental allergy, chronic myeloid leukemia and overactive bladder. Past drug history included fluticasone propionate, salmeterol xinafoate (ADVAIR) 100/50 twice daily inhalation taken for asthma from an unspecified start date and ongoing, azelastine hydrochloride, fluticasone propionate (DYMISTA) 1 spray each nostril twice daily taken for environmental allergy from an unspecified start date and ongoing; dasatinib monohydrate (SPRYCEL, NDC: 0003-0524-11) 70 mg, one tablet every evening taken for chronic myeloid leukaemia from 2013 to an unspecified stop date; spironolactone (SPIRONOLACTONE) 25 mg once daily taken for fluid retention from 2017 to an unspecified stop date and mirabegron (MYRBETRIQ) 50 mg once daily by mouth taken for hypertonic bladder, start and stop date were not reported. On an unspecified date, the patient experienced some throat tightness the day of the COVID vaccine that dissipated late that afternoon and that was for both doses. Caller was calling about the Pfizer BioNtech COVID vaccine. She had some throat tightness the day of the COVID vaccine that dissipated late that afternoon and that was for both doses. The outcome of the event both doses, throat tightness was recovered on an unspecified date.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Vomiting-progressively worse, not eating, child seems to be in pain. Ended up in ER-laparoscopic converted to open reduction of Intussusception with appendectomy.
Pt returned to the pharmacy 10 or 15 following administration of her 2nd dose stating her throat was getting itchy.  (pt was waiting in hallway)  Pt was given oral a Diphenhydramine 50mg capsule at 9:25am.  Pulse was 118.  Pt was still red faced and reporting that she was hot at 9:30am.  Pt was given 10ml Diphenhydramine 12.5/5ml at 9:33.  Paramedics arrived at 9:45.  O2 sats were 100%.  Breath sounds were good.  Pt choose to go to hospital b/c she would be alone at home.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician) for a Pfizer sponsored program.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 29Nov2021, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (29Nov2021) positive. Additional Context: the physician called about the pediatric COVID-19 vaccine. He had a 10-12 year old patient that received the 1st dose of the COVID-19 vaccine about a month ago, and then contracted COVID-19 on 29Nov2021.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the reported information ,a causal relationship between the events and suspected drug cannot be excluded.
It was a little bit of soreness on my right knee, It was so bad where it was difficult to walk or stand on it. That's when I decided to call my Orthopedic and I was seen 03/03/2022 I was put on steroid orally and injected my left knee with an anti inflammatory. At that time I was off work for 5 weeks and I was also put on crutches, I was able to return back to work 04/07/2021 after the 5 week using my crutches and having the second dose of my injection. I went back to the Doctor 04/12/2021 and went back to work on May 10th, 2021. My left knee is doing a lot better and I did not have any further days off or nothing. I'm pretty much back to normal with my left knee.
Shingles worsen after the second shot; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles worsen after the second shot) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles worsen after the second shot). At the time of the report, HERPES ZOSTER (Shingles worsen after the second shot) outcome was unknown. Not Provided          No concomitant medications reported. No treatment reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-065349 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065349:Cross-linked
pt recv vax;on clinic visit 25oct94, mom reported staring spells for 3-4 days p/ DTP;referred to MD; MD insisted to hold Pertussis & give DT;
an unspecified human papillomavirus vaccine; No additional AEs reported; first dose of an unspecified human papillomavirus vaccine in June 2018. The patient received a first dose of an unspecified human papillomavirus vaccine in June 2018. The patient received a; This spontaneous report as received from a physician's assistant refers to an adolescent patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported.  On an unknown date in June 2018, at 16 years old, the patient was vaccinated with an unspecified human papillomavirus vaccine (manufacturer unknown) (exact dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. On an unknown date in July 2019, the patient received the second dose of an unspecified human papillomavirus vaccine (manufacturer unknown) (exact dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis (product origin unknown and inappropriate schedule of product administration). No adverse effects were reported.